Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Evaluation of oral T2 (chloroform/methanol extract of Tripterygium wilfordii Hook F) in the
treatment of RA patients with clinical efficacy and safety.Open-labeled, randomized,
prospective multi-center clinical trial. Observation period of 24 weeks.